Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis

被引:48
|
作者
Filiopoulos, Vassilis [1 ]
Hadjiyannakos, Dimitrios [1 ]
Takouli, Lambrini [1 ]
Metaxaki, Polixeni [1 ]
Sideris, Vasilis [2 ]
Vlassopoulos, Dimosthenis [1 ]
机构
[1] Amalia Fleming Hosp, Dept Nephrol, Athens 14121, Greece
[2] Pendeli Pediat Hosp, Dept Hematol, Athens, Greece
来源
关键词
End-stage renal disease; Hemodialysis; Peritoneal dialysis; Inflammation; Oxidative stress; C-REACTIVE-PROTEIN; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HYPERHOMOCYSTEINEMIA; MICROINFLAMMATION; DYSLIPIDEMIA; SERUM; IRON;
D O I
10.1177/039139880903201206
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Purpose: The impact of different dialysis modalities on oxidative stress and inflammation and the factors implicated in this interrelationship have not been adequately studied. This study was designed to comparatively evaluate the effect of hemodialysis (HD) and peritoneal dialysis (PD) on oxidative stress and inflammatory biomarkers and to search for associated factors. Methods: We studied 20 HD, 11 PD patients and 11 healthy controls. Calculations were based on total antioxidant capacity (TAC) and superoxide dismutase (SOD), by spectrophotometry, as oxidative stress biomarkers; and high sensitivity CRP (hs-CRP), Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), by ELISA, as inflammation biomarkers. Results: HD and PD patients showed significantly increased levels of TAC, SOD and hs-CRP compared to healthy controls. No significant difference was observed in TNF-alpha and IL-6. Compared to HD patients, PD patients showed TNF-alpha levels that were increased, although non-significantly, and significantly higher homocysteine (Hcy). No differences were observed for IL-6, hs-CRP, TAC and SOD. In HD patients, significant positive correlations were found between intact parathyroid hormone (iPTH) and TNF-alpha, and between uric acid (UA) and TAC. beta 2-microglobulin (beta 2M) was negatively correlated with TAC, total cholesterol (TC) positively with TNF-alpha and negatively with SOD, and triglycerides (TG) correlated positively with TNF-alpha. In PD patients, TG correlated positively with TNF-alpha, HDL-cholesterol negatively with TNF-alpha, LDL-cholesterol negatively with SOD, and beta 2M negatively with SOD. Conclusions: HD and PD patients show similar degrees of inflammation and oxidative stress activation. Factors such as UA, iPTH, beta 2M and lipid profile correlate to oxidative stress and inflammatory biomarkers in both HD and PD patients. (Int J Artif Organs 2009; 32: 872-82)
引用
收藏
页码:872 / 882
页数:11
相关论文
共 50 条
  • [1] Comparison of arterial stiffness in end-stage renal disease patients treated with peritoneal dialysis or hemodialysis
    Strozecki, Pawel
    Donderski, Rafal
    Kardymowicz, Anna
    Manitius, Jacek
    [J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2012, 122 (1-2): : 33 - 38
  • [2] Similar Outcomes With Hemodialysis and Peritoneal Dialysis in Patients With End-Stage Renal Disease
    Mehrotra, Rajnish
    Chiu, Yi-Wen
    Kalantar-Zadeh, Kamyar
    Bargman, Joanne
    Vonesh, Edward
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (02) : 110 - 118
  • [3] Obese and diabetic patients with end-stage renal disease: Peritoneal dialysis or hemodialysis?
    Ekart, Robert
    Hojs, Radovan
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 32 : 1 - 6
  • [4] Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis
    Vonesh, EF
    Moran, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (02): : 354 - 365
  • [5] Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease
    Alloatti, S
    Manes, M
    Paternoster, G
    Gaiter, AM
    Molino, A
    Rosati, C
    [J]. JOURNAL OF NEPHROLOGY, 2000, 13 (05) : 331 - 342
  • [6] Metallothionein and dendritic cells in skin of end-stage renal disease patients not on dialysis, or on hemodialysis or peritoneal dialysis
    Alscher, DM
    Bruckner, A
    Fritz, P
    Kimmel, M
    Stoeltzing, H
    Kuhlmann, U
    Mettang, T
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2002, 22 (04): : 449 - 453
  • [7] Pheochromocytoma in end-stage renal disease patient treated by peritoneal dialysis
    Gorsane, Imen
    Zouaghi, Karim
    Goucha, Rim
    Bacha, Mohamed Mongi
    Hedri, Hafedh
    Khiari, Karima
    Abderrahim, Ezzedine
    Ben Abdallah, Taieb
    Ben Abdallah, Nejib
    Ben Moussa, Fatma
    Ben Maiz, Hedi
    Kheder, Adel
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2008, 4 (07): : 597 - 601
  • [8] Effects of hemodialysis, peritoneal dialysis, and renal transplantation on the quality of life of patients with end-stage renal disease
    Zhang, Lijuan
    Guo, Yannan
    Ming, Hua
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (09): : 1229 - 1234
  • [9] Cost Comparison of Peritoneal Dialysis Versus Hemodialysis in End-Stage Renal Disease
    Berger, Ariel
    Edelsberg, John
    Inglese, Gary W.
    Bhattacharyya, Samir K.
    Oster, Gerry
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (08): : 509 - 518
  • [10] Comparison of the effect of hemodialysis and peritoneal dialysis in the treatment of end-stage renal disease
    Zhao, Yuan
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (06) : 1562 - 1567